SCHEMBL13291213

SCHEMBL13291213

CC(C)(C)c1ccc(-n2c3ccccc3c3cc(N(c4ccc(-c5ccc6ccccc6c5)cc4)c4ccc(-c5c6ccccc6c(-c6ccccc6)c6ccccc56)cc4)ccc32)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTGES O14684 3/20 0.38
▸ PPARG P37231 4/20 0.36
▸ PPARA Q07869 2/20 0.35
▸ TSPO P30536 2/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ MAPT P10636 1/20 0.34
▸ MAPK1 P28482 1/20 0.34
▸ NPSR1 Q6W5P4 1/20 0.34
▸ ATM Q13315 2/20 0.33
▸ KDM4E B2RXH2 1/20 0.33
▸ L3MBTL1 Q9Y468 1/20 0.33
▸ SERPINE1 P05121 1/20 0.33
▸ GPR84 Q9NQS5 1/20 0.32
▸ KMT2A Q03164 1/20 0.32
▸ TUBB4A P04350 1/20 0.31
▸ TUBB P07437 1/20 0.31
▸ TUBA3C P0DPH7 1/20 0.31
▸ TUBA1B P68363 1/20 0.31
▸ TUBA4A P68366 1/20 0.31
▸ TUBB4B P68371 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13291155 0.97 PTGES (0.37) PTGESPPARGPPARATSPOALDH1A1
SCHEMBL13291236 0.95 PTGES (0.37) PTGESPPARGPPARATSPOALDH1A1
SCHEMBL13291229 0.93 PTGES (0.35) PTGESPPARGTSPOALDH1A1MAPT
SCHEMBL13291142 0.91 L3MBTL1 (0.41) PTGESTSPOALDH1A1MAPTATM
SCHEMBL13291143 0.91 L3MBTL1 (0.41) PTGESTSPOALDH1A1MAPTATM
SCHEMBL13291166 0.91 L3MBTL1 (0.41) PTGESTSPOALDH1A1MAPTATM
SCHEMBL13291140 0.91 L3MBTL1 (0.41) PTGESTSPOALDH1A1MAPTATM
SCHEMBL13291146 0.91 L3MBTL1 (0.41) PTGESTSPOALDH1A1MAPTATM
SCHEMBL10098602 0.91 PPARG (0.38) PTGESPPARGPPARATSPOALDH1A1
SCHEMBL24827725 0.91 PPARG (0.39) PTGESPPARGPPARATSPOALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100156957-A1 ORGANIC COMPOUND, ANTHRACENE DERIVATIVE, AND LIGHT-EMITTING ELEMENTS, LIGHT-EMITTING DEVICES, ELECTRONIC DEVICES, AND LIGHTING DEVICES USING THE ANTHRACENE DERIVATIVE SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2010-06-24 — — US disclosed
US-20100156957-A1 ORGANIC COMPOUND, ANTHRACENE DERIVATIVE, AND LIGHT-EMITTING ELEMENTS, LIGHT-EMITTING DEVICES, ELECTRONIC DEVICES, AND LIGHTING DEVICES USING THE ANTHRACENE DERIVATIVE SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2010-06-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100156957-A1 ORGANIC COMPOUND, ANTHRACENE DERIVATIVE, AND LIGHT-EMITTING ELEMENTS, LIGHT-EMITTING DEVICES, ELECTRONIC DEVICES, AND LIGHTING DEVICES USING THE ANTHRACENE DERIVATIVE GLB1, CYP1A1, CRY1 PTGES 154/4885PPARG 367/4885PPARA 1641/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback